Decoding Mitochondrial Peptides SS-31

The transcript examines the anti-aging peptide SS-31, explaining that its effectiveness depends entirely on whether an individual possesses damaged mitochondria with degraded structural fats that the compound can physically repair. While clinical trials struggled with broad physical metrics, the FDA ultimately approved the drug after observing specific leg strength improvements in patients with severe underlying conditions. The speaker emphasizes that healthy cells experience little to no benefit from the peptide, meaning that people without genuine cellular degradation will likely waste…